'Pivotal Time For CROs': ICON CEO Cutler On Changing APAC Trial Trends

 
• By Lisa Takagi

The CEO of one the global top-five CROs points out a larger opportunity in decentralized trials that might be a “game changer” in the global pharma industry over the next five years. He also refers to the need to accept new technologies by both clinical trial sites and regulators.

Dr. Steve Cutler, CEO of ICON (left) and Dr. Atsushi Ogawa, general manager of ICON Japan (right) joined an exclusive interview with Scrip.
ICON CEO Steve Cutler (left) and Atsushi Ogawa, general manager of ICON Japan, in an exclusive interview with Scrip • Source: Lisa Takagi

More from Focus On Asia

More from Scrip